137 related articles for article (PubMed ID: 34727247)
1. Native T1 mapping of the breast in MRI to differentiate fibroadenomas from benign phyllodes tumors: a preliminary study.
Yalcin A; Goktepeli M; Taydas O; Sayar I
MAGMA; 2022 Jun; 35(3):441-447. PubMed ID: 34727247
[TBL] [Abstract][Full Text] [Related]
2. Cellular fibroepithelial lesions diagnosed on core needle biopsy: Is there any role of clinical-sonography features helping to differentiate fibroadenomas and phyllodes tumor?
Al-Arnawoot B; Scaranelo A; Fleming R; Kulkarni S; Menezes RJ; McCready D; Done S; Freitas V
J Surg Oncol; 2020 Sep; 122(3):382-387. PubMed ID: 32396665
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonography and core needle biopsy in the differential diagnosis of fibroadenoma and tumor phyllodes.
Bode MK; Rissanen T; Apaja-Sarkkinen M
Acta Radiol; 2007 Sep; 48(7):708-13. PubMed ID: 17728999
[TBL] [Abstract][Full Text] [Related]
4. Differentiation between benign phyllodes tumors and fibroadenomas of the breast on MR imaging.
Kamitani T; Matsuo Y; Yabuuchi H; Fujita N; Nagao M; Kawanami S; Yonezawa M; Yamasaki Y; Tokunaga E; Kubo M; Yamamoto H; Honda H
Eur J Radiol; 2014 Aug; 83(8):1344-9. PubMed ID: 24856515
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between phyllodes tumor and fibroadenoma using real-time elastography.
Adamietz BR; Kahmann L; Fasching PA; Schulz-Wendtland R; Uder M; Beckmann MW; Meier-Meitinger M
Ultraschall Med; 2011 Dec; 32 Suppl 2():E75-9. PubMed ID: 22194044
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between phyllodes tumours and fibroadenomas using intravoxel incoherent motion magnetic resonance imaging: comparison with conventional diffusion-weighted imaging.
Kawashima H; Miyati T; Ohno N; Ohno M; Inokuchi M; Ikeda H; Gabata T
Br J Radiol; 2018 Apr; 91(1084):20170687. PubMed ID: 29231040
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of phyllodes breast tumors from fibroadenomas on MRI.
Wurdinger S; Herzog AB; Fischer DR; Marx C; Raabe G; Schneider A; Kaiser WA
AJR Am J Roentgenol; 2005 Nov; 185(5):1317-21. PubMed ID: 16247156
[TBL] [Abstract][Full Text] [Related]
8. Audit of fibroepithelial tumors of the breast in a Nigerian tertiary institution.
Daramola AO; Oguntunde OA; Awolola NA
Niger J Clin Pract; 2016; 19(5):645-8. PubMed ID: 27538554
[TBL] [Abstract][Full Text] [Related]
9. MRI-based radiomics analysis for differentiating phyllodes tumors of the breast from fibroadenomas.
Tsuchiya M; Masui T; Terauchi K; Yamada T; Katyayama M; Ichikawa S; Noda Y; Goshima S
Eur Radiol; 2022 Jun; 32(6):4090-4100. PubMed ID: 35044510
[TBL] [Abstract][Full Text] [Related]
10. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.
Lawton TJ; Acs G; Argani P; Farshid G; Gilcrease M; Goldstein N; Koerner F; Rowe JJ; Sanders M; Shah SS; Reynolds C
Int J Surg Pathol; 2014 Dec; 22(8):695-8. PubMed ID: 25161205
[TBL] [Abstract][Full Text] [Related]
11. Imaging and Management of Fibroepithelial Lesions of the Breast: Radiologic-Pathologic Correlation.
Zhang M; Arjmandi FK; Porembka JH; Seiler SJ; Goudreau SH; Merchant K; Hwang H; Hayes JC
Radiographics; 2023 Nov; 43(11):e230051. PubMed ID: 37856317
[TBL] [Abstract][Full Text] [Related]
12. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
13. Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.
Wang Y; Resnick MB; Lu S; Hui Y; Brodsky AS; Yang D; Yakirevich E; Wang L
Hum Pathol; 2016 Nov; 57():176-181. PubMed ID: 27498063
[TBL] [Abstract][Full Text] [Related]
14. Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing.
Ng CCY; Md Nasir ND; Loke BN; Tay TKY; Thike AA; Rajasegaran V; Liu W; Lee JY; Guan P; Lim AH; Chang KTE; Gudi MA; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Yip GWC; Bay BH; Tan P; Teh BT; Tan PH
Mod Pathol; 2021 Jul; 34(7):1320-1332. PubMed ID: 33727697
[TBL] [Abstract][Full Text] [Related]
15. Fibroepithelial Lesions in the Breast of Adolescent Females: A Clinicopathological Study of 54 Cases.
Ross DS; Giri DD; Akram MM; Catalano JP; Olcese C; Van Zee KJ; Brogi E
Breast J; 2017 Mar; 23(2):182-192. PubMed ID: 28299887
[TBL] [Abstract][Full Text] [Related]
16. A Radiomics Approach for the Classification of Fibroepithelial Lesions on Breast Ultrasonography.
Sim Y; Lee SE; Kim EK; Kim S
Ultrasound Med Biol; 2020 May; 46(5):1133-1141. PubMed ID: 32102739
[TBL] [Abstract][Full Text] [Related]
17. Can phyllodes tumours of the breast be distinguished from fibroadenomas using fine needle aspiration cytology?
Scolyer RA; McKenzie PR; Achmed D; Lee CS
Pathology; 2001 Nov; 33(4):437-43. PubMed ID: 11827409
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesis.
Lien HC; Huang CS; Yang YW; Jeng YM
Histopathology; 2016 Feb; 68(3):433-41. PubMed ID: 26109290
[TBL] [Abstract][Full Text] [Related]
19. Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.
Piscuoglio S; Ng CK; Murray M; Burke KA; Edelweiss M; Geyer FC; Macedo GS; Inagaki A; Papanastasiou AD; Martelotto LG; Marchio C; Lim RS; Ioris RA; Nahar PK; Bruijn ID; Smyth L; Akram M; Ross D; Petrini JH; Norton L; Solit DB; Baselga J; Brogi E; Ladanyi M; Weigelt B; Reis-Filho JS
J Pathol; 2016 Mar; 238(4):508-18. PubMed ID: 26832993
[TBL] [Abstract][Full Text] [Related]
20. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
